REN and neoplasm: Building on our findings, direct modulation of REN activity to reinvigorate NK cell cytotoxicity, as well as targeted inhibition of its downstream signaling pathways, holds the potential to disrupt the immunosuppressive tumor microenvironment and overcome tumor stemness-driven resistance.